Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma

Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma

Purpose: To investigate the neuroprotective effect of riluzole through matrix metalloproteinase-2 (MMP-2) and MMP-9 in rats, in an experimental glaucoma model. Methods: A total of 28 Wistar albino rats, 3–4 months old, weighing 250–300 g, were divided into four groups; Group I (control), Group II (g...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fatma Yildiz, Nedime Sahinoglu-Keskek, Işıl Tan Yilmaz, İbrahim Aydin Candan, Orhan Tansel Korkmaz
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-04-01
Series:	Journal of Current Ophthalmology
Subjects:	glaucoma intraocular pressure matrix metalloproteinase-2 matrix metalloproteinase-9 neuroprotection riluzole
Online Access:	https://journals.lww.com/10.4103/joco.joco_290_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Content of matrix metalloproteinases in the intraocular fluid of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2020-11-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Features of the level of matrix metalloproteinase-2, -3, -9 and tissue inhibitors of metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2022-01-01)

Assessment of Matrix Metalloproteinases a Prognostic Indicator in Advanced Fibrotic Lung Disease: A Systematic Review
by: Mehvish Aqil, et al.
Published: (2025-04-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

The analysis of MMP2, MMP3 and MMP9 matrix metalloproteinases genes polymorphism among Russian Caucasian patients with primary open-angle glaucoma
by: A.V. Shevchenko, et al.
Published: (2023-03-01)

SYSTEM OF MATRIX METALLOPROTEINASES IN THE EVALUATION OF LUNG TISSUE DESTRUCTION IN TUBERCULOSIS
by: D. S. Esmedlyaeva, et al.
Published: (2015-08-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
by: K. V. Sirotkina, et al.
Published: (2023-09-01)

The presence of promatrix metalloproteinase-3 and its relation with different categories of coal workers' pneumoconiosis
by: Remzi Altin, et al.
Published: (2004-01-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

Changes in matrix metalloproteinases and their inhibitors in the tears and blood serum of patients with herpetic keratoconjunctivitis under the influence of antiherpetic antibodies and nimesulide
by: P. H. Pantielieiev, et al.
Published: (2021-05-01)

Exploring the Causal Relationship Between the Plasma Levels of MMP1 (Matrix Metalloproteinase‐1), MMP3, MMP7, MMP10, and MMP12 and Intervertebral Disc Degeneration: Mendelian Randomization
by: Lin Sun, et al.
Published: (2025-03-01)

Clinical and prognostic significance of matrix metalloproteinases in patients with myocardial infarction
by: T. B. Pecherina, et al.
Published: (2019-06-01)

Dynamic changes of serum matrix metalloproteinases and tissue inhibitors in Kawasaki disease: implications for coronary artery lesions persistence
by: Yaqi Li, et al.
Published: (2025-06-01)

Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal
by: M. Ζafrakas, et al.
Published: (2020-04-01)

Matrix metalloproteinases (MMP-1, -8, -13) in chronic periapical lesions
by: Andonovska Biljana, et al.
Published: (2008-01-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

Research advances of matrix metalloproteinases family in uveal melanoma
by: Yuning Chen, et al.
Published: (2025-07-01)

Gender peculiarities and prognostic value of matrix metalloproteinase and their inhibitors system in patients with acute Q-wave left ventricle myocardial infarction
by: S. M. Kyselov
Published: (2015-02-01)

EXPRESSION OF MATRIX METALLOPROTEINASES IN LACRIMAL FLUID AND GENE POLYMORPHISM OF COMPLEMENT FACTOR H (CFH) IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
by: V. A. Sokolov, et al.
Published: (2017-10-01)

Matrix Metalloproteinases 7 and 10 Are Prognostic Biomarkers for Systemic Cardiovascular Risk in Individuals with Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-06-01)

Matrix metalloproteinase-8 in early diagnostics of generalized periodontitis
by: O. O. Fastovets, et al.
Published: (2018-10-01)

ISCHEMIC INJURY OF KIDNEY ALLOGRAFTS AND EXPRESSION OF MATRIX METALLOPROTEINASES
by: M. L. Arefjev, et al.
Published: (2011-06-01)

Inhibition of matrix metalloproteinases: a troubleshooting for dentin adhesion
by: Izadora Quintela Souza de Moraes, et al.
Published: (2020-08-01)

Matrix Metalloproteinases in Ureteropelvic Junction Obstruction: Their Role in Pathogenesis and Their Use as Clinical Markers
by: Giusi Alberti, et al.
Published: (2025-03-01)

Effects of matrix metalloproteinase inhibition in cultured human Tenon’s capsule fibroblasts
by: Na Hyun Kim, et al.
Published: (2025-07-01)

Gelatinases A and B activities in the serum of patients with various coronary artery disease stages
by: Radenković Sandra, et al.
Published: (2010-01-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2024-04-01)

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
by: Ane Caroline Thé B Freire, et al.
Published: (2025-01-01)

Influence of thrombolytic therapy on the condition of matrix metalloproteinase and their inhibitors system in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2014-08-01)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 expression is upregulated in congenital lung malformations
by: Ayşe Parlak, et al.
Published: (2025-02-01)